erythrosine and bortezomib

erythrosine has been researched along with bortezomib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Chiang, AK; Hui, KF	1
Boháčová, V; Breier, A; Kyca, T; Mišák, A; Pavlíková, L; Poturnayová, A; Šereš, M; Sulová, Z	1

Other Studies

2 other study(ies) available for erythrosine and bortezomib

Article	Year
Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism. International journal of cancer, 2014, Dec-15, Volume: 135, Issue:12 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Boronic Acids; Bortezomib; Carcinoma; Caspases; Cell Proliferation; Depsipeptides; DNA Damage; Endoplasmic Reticulum Stress; Enzyme Activation; Female; Fluoresceins; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; In Situ Nick-End Labeling; Mice; Mice, Inbred BALB C; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Peptides, Cyclic; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Pyridines; Reactive Oxygen Species	2014
Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells. International journal of molecular sciences, 2021, May-23, Volume: 22, Issue:11 Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bortezomib; Cell Cycle; Cell Division; Cell Line, Tumor; Deubiquitinating Enzymes; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Gene Expression Regulation, Neoplastic; Genes, cdc; Humans; Inhibitory Concentration 50; Leukemia, Lymphoid; Mice; Neoplasm Proteins; Protease Inhibitors; Proteasome Endopeptidase Complex; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Ubiquitinated Proteins; Vincristine	2021

Article

Year

Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism.

International journal of cancer, 2014, Dec-15, Volume: 135, Issue:12

Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Boronic Acids; Bortezomib; Carcinoma; Caspases; Cell Proliferation; Depsipeptides; DNA Damage; Endoplasmic Reticulum Stress; Enzyme Activation; Female; Fluoresceins; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; In Situ Nick-End Labeling; Mice; Mice, Inbred BALB C; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Peptides, Cyclic; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Pyridines; Reactive Oxygen Species

2014

Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells.

International journal of molecular sciences, 2021, May-23, Volume: 22, Issue:11

Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bortezomib; Cell Cycle; Cell Division; Cell Line, Tumor; Deubiquitinating Enzymes; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Gene Expression Regulation, Neoplastic; Genes, cdc; Humans; Inhibitory Concentration 50; Leukemia, Lymphoid; Mice; Neoplasm Proteins; Protease Inhibitors; Proteasome Endopeptidase Complex; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Ubiquitinated Proteins; Vincristine

2021